Novacyt confirms end of Yourgene Taiwan disposal discussions

6th Feb 2024 12:48

(Sharecast News) - Novacyt announced on Tuesday that it had received formal notification from INEX Innovate terminating discussions around the acquisition of Yourgene Health Taiwan.

The AIM-traded firm noted that Yourgene Health initially announced the acquisition on 13 June 2023.

As a result of the termination, Yourgene's Taiwanese laboratory business would remain within the Novacyt group.

"The board does not consider the divestment material and will continue to evaluate a number of options in relation to the future of the Taiwanese laboratory business that offer the best value to all stakeholders," the Novacyt board said in its statement.

At 1158 GMT, shares in Novacyt were down 5.77% at 47.35p.

Reporting by Josh White for Sharecast.com.

Top Risers

Share	Price	Change
Clontarf (CLON)	0.0425	26.87%
Hunting (HTG)	435.00	16.78%
Itim Grou (ITIM)	39.50	12.86%
4global (4GBL)	54.00	12.5%
Keller (KLR)	1,270.00	11.8%

Top Fallers

Share	Price	Change
Oracle Power (ORCP)	0.019	-36.67%
ValiRx (VAL)	2.15	-29.51%
Lifesafe Hldg (LIFS)	12.50	-26.47%
Vast Res (VAST)	0.235	-24.19%
Supply@me Cap (SYME)	0.02	-18.37%

Top By Volume

Share	Price	Volume
Supply@me Cap (SYME)	0.02	403,548,559
Clontarf (CLON)	0.0425	255,829,600
Inspirit Energy (INSP)	0.0075	50,000,000
Vast Res (VAST)	0.235	33,006,841
Vela Technologies (VELA)	0.012	31,533,498

All prices are delayed by at least 15 minutes. Share Compare cannot be held responsible for the accuracy of share prices shown on this website, and investors should be aware that share prices can go down as well as up. Share Compare does not offer advice, and is not regulated by the Financial Conduct Authority.